This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Lee, C. J. Articles by Simeone, D. M. PubMed PubMed Citation Articles by Lee, C. J. Articles by Simeone, D. M.

Pancreatic Cancer Stem Cells

Cheong J. Lee, Joseph Dosch, Diane M. Simeone

From the Departments of Surgery, Internal Medicine, and Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI

Corresponding author: Diane M. Simeone, MD, Surgery and Molecular and Integrative Physiology, TC 2210B, Box 5343, University of Michigan Medical Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109; e-mail: simeone{at}umich.edu

Cellular heterogeneity in cancer was observed decades ago by studies in mice which showed that distinct subpopulations of cells within a tumor mass are capable of driving tumorigenesis. Conceptualized from this finding was the stem-cell hypothesis for cancer, which suggests that only a specific subset of cancer cells within each tumor is responsible for tumor initiation and propagation, termed tumor initiating cells or cancer stem cells (CSCs). Recent data has been provided to support the existence of CSCs in human blood cell–derived cancers and solid organ tumors of the breast, brain, prostate, colon, and skin. Study of human pancreatic cancers has also revealed a specific subpopulation of cancer cells that possess the characteristics of CSCs. These pancreatic cancer stem cells express the cell surface markers CD44, CD24, and epithelial-specific antigen, and represent 0.5% to 1.0% of all pancreatic cancer cells. Along with the properties of self-renewal and multilineage differentiation, pancreatic CSCs display upregulation of important developmental genes that maintain self-renewal in normal stem cells, including Sonic hedgehog (SHH) and BMI-1. Signaling cascades that are integral in tumor metastasis are also upregulated in the pancreatic CSC. Understanding the biologic behavior and the molecular pathways that regulate growth, survival, and metastasis of pancreatic CSCs will help to identify novel therapeutic approaches to treat this dismal disease.

Supported by grants provided by the Lustgarten Foundation and Elsa Pardee Foundation (D.M.S.).

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

This article has been cited by other articles:

				B. M. Boman and M. S. Wicha Cancer Stem Cells: A Step Toward the Cure J. Clin. Oncol., June 10, 2008; 26(17): 2795 - 2799. [Full Text] [PDF]